Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001005286-24-000139
Filing Date
2024-09-23
Accepted
2024-09-23 16:21:16
Documents
22
Period of Report
2024-11-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A lndc-20240923.htm   iXBRL DEF 14A 884073
6 GRAPHIC lndc-20240923_g1.jpg GRAPHIC 19503
7 GRAPHIC lndc-20240923_g2.gif GRAPHIC 58193
8 GRAPHIC lndc-20240923_g3.gif GRAPHIC 58411
9 GRAPHIC lndc-20240923_g4.gif GRAPHIC 54110
10 GRAPHIC lndc-20240923_g5.jpg GRAPHIC 529032
11 GRAPHIC lndc-20240923_g6.jpg GRAPHIC 251348
12 GRAPHIC lndc-20240923_g7.jpg GRAPHIC 485698
13 GRAPHIC lndc-20240923_g8.jpg GRAPHIC 250847
  Complete submission text file 0001005286-24-000139.txt   5738164

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20240923.xsd EX-101.SCH 2637
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lndc-20240923_def.xml EX-101.DEF 3043
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20240923_lab.xml EX-101.LAB 3479
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20240923_pre.xml EX-101.PRE 2095
24 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20240923_htm.xml XML 224761
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
Type: DEF 14A | Act: 34 | File No.: 000-27446 | Film No.: 241316472
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)